ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q3Scopus Q1SCImago #2,874Hybrid

Journal of Immunotherapy and Precision Oncology

Identifier (ISSN):2666-2345(Print)/2590-017X(Online)
•
Publisher:Innovative Healthcare Institute
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
3.1↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2024–2026)

Clarivate IF trend for Journal of Immunotherapy and Precision Oncology

WoS Q3
0235020243.220253.12026
Annual Impact Factor Metric
Current (2026):3.1
Scopus SJR & RankScopus Q1
1.37
#2,874

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
15

15 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
6articles/year
96.39% Gold OA•0% Original Research

Aims & Scope

Journal of Immunotherapy and Precision Oncology (ISSN: 2666-2345) is a peer-reviewed international scholarly journal in the field of Medicine, published by Innovative Healthcare Institute. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 1.370 (Q1), an H-index of 15.

Topics Covered (Recognized by AI)
Medicine91%Biology85%Internal medicine82.7%Genetics75.2%Cancer58.6%Pathology53.4%Immunology52.6%Chemistry45.9%Immune system42.1%Biochemistry41.4%Oncology39.8%Surgery36.1%Immunotherapy34.6%Cancer research24.1%Pharmacology23.3%Computer science23.3%Adverse effect21.1%Gene20.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

IMMUNOLOGY

Q3
Rank108/183
IndexESCI
JCRESCI2026

ONCOLOGY

Q2
Rank165/333
IndexESCI
JCIESCI2026

IMMUNOLOGY

Q3
Rank124/183
IndexESCI
JCIESCI2026

ONCOLOGY

Q3
Rank206/333
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

10 year
2026Latest
IF3.1
Articles / Year6
Total Citations0
2025
IF3.2
Articles / Year30
Total Citations48
2024
IF0
Articles / Year32
Total Citations130
2023
IF—
Articles / Year31
Total Citations262
2022
IF—
Articles / Year24
Total Citations307

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,874Scopus Q1SCImago Profile
Scopus Coverage:2018-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
1.37

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.00

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,193 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations272
3-Year Documents78
Citable Documents69

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1
Immunology and AllergyQ1
OncologyQ1
Cancer ResearchQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Immunotherapy and Precision Oncology (ISSN: 2666-2345) is a peer-reviewed international scholarly journal in the field of Medicine, published by Innovative Healthcare Institute. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 1.370 (Q1), an H-index of 15.

The journal enforces rigorous peer evaluation with an annual output of approximately 6 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,193 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Innovative Healthcare Institute
Publication Language
English
Frequency
Periodic
Indexing & Databases
ScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 79bf91bc-4467-4794-b00d-25c247077055
Database Updated: 2026-10-01